“Cost Allocation Company” (“the taxpayer”), a Greek holding company, provides administrative support services to its subsidiaries. For 2020 to 2023 it priced these under TNMM, using a net margin on operating costs, and excluded costs it treated as shareholder activities under para 7.10 of the OECD Guidelines. The exclusions turned operating margins of about -30% to -44% into a positive 6.50%, near the median of its range. The tax authority applied TNMM to total operating costs and reduced losses carried forward.
Assessee’s Contentions | Revenue’s Contentions | Court’s Judgement |
The taxpayer contended that the audit arbitrarily rejected its documented cost allocation, unlawfully reversed the burden of proof and failed to assess the evidence it had submitted. | The tax authority’s position was that the cost allocation evidence was insufficient, the separation of shareholder functions from services was not shown in line with the OECD Guidelines, and no substantiated benefit test had been performed. | The Directorate found the cost allocation supported only by summary tables, without a verifiable audit trail or links to source data; man-hour allocations could not be checked. TNMM depends on a stable, verifiable cost base, which was lacking. |
It pleaded legitimate expectations, as the same methodology and a similar cost base had been accepted in an earlier audit and in an audit of a subsidiary, and asked that the loss reduction be set aside pending its judicial appeal. | The authority maintained that the taxpayer was not a low-risk routine entity, that Article 48(4) of Law 4172/2013 barred deduction of costs linked to participations yielding exempt dividends, and that each year is examined separately. | Cumulative adjustments without a documented or agreed true-up mechanism were a retrospective adjustment of results, not an ex ante pricing policy. Landing at the median did not prove compliance, and the low-risk label was contradicted by persistent losses. |
The appeal was dismissed and the assessments for 2020 to 2023 confirmed. The exclusion of shareholder costs from the TNMM cost base was not accepted without a verifiable audit trail and a substantiated benefit test.

